Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:11:39.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T20:36:08.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed on the page, replacing the prior Revision: v3.4.2. This update concerns revision history metadata and does not alter the study content.
    Difference
    0.0%
    Check dated 2026-03-11T17:53:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Removed the old government funding operating-status notice and the prior Revision: v3.4.1; added Revision: v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:16:38.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding has been added, informing users that information may not be up to date and the NIH Clinical Center is open with status updates at opm.gov. The page version indicator was updated to Revision: v3.4.1 and the previous Revision: v3.4.0 was removed.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:40.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Glossary toggle is now visible on the page. The page now displays a 'Last Update Submitted that Met QC Criteria' label, includes a 'No FEAR Act Data' notice, and shows 'Revision: v3.4.0' in the footer.
    Difference
    0.2%
    Check dated 2026-01-28T02:37:24.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.